Summary
The efficacy of nimesulide (100mg twice daily) was compared with that of naproxen (500mg twice daily) in 53 adult patients with nonbacterial acute inflammation of the ear, nose or throat in a double-blind phase III clinical investigation. Both drugs were administered orally after meals for a mean duration of 8.7 days.
In this setting, nimesulide was associated with relief of pain and inflammatory signs (exudation and swelling). Indeed, treatment with nimesulide led to clinical improvement superior to that obtained with naproxen in terms of both rapidity of action and improvement of the symptoms at the end of therapy.
Nimesulide therapy was also very well tolerated and no patient reported an adverse event. In contrast, 2 naproxen-treated patients reported episodic gastralgia of moderate intensity.
Similar content being viewed by others
References
Nouri EM. Nimesulide for treatment of acute inflammation of the upper respiratory tract. Clinical Therapy 6: 142, 1984
Ottaviani A, Mantovani M, et al. Studio policentrico sull’efficacia clinica e la tollerabilità della nimesulide nelle affezioni flogistiche otorinolaringoiatriche. Otorinolaringologia 39: 579–588, 1989
Rossi M, Monea P, Lomeo G, et al. Studio clinico sull’efficacia e la tollerabilità della nimesulide in formulazione supposte in patologie algico-infiammatorie otorinolaringoiatriche. Minerva Medica 81: 31–38, 1990
Ward A, Brogden RN. Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states. Drugs 36: 732–753, 1988
Author information
Authors and Affiliations
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/BF03260137.
Rights and permissions
About this article
Cite this article
Nouri, E., Monti, T. Nimesulide Granules for the Treatment of Acute Inflammation of the Ear, Nose or Throat. Drugs 46 (Suppl 1), 103–106 (1993). https://doi.org/10.2165/00003495-199300461-00021
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199300461-00021